(Q44027179)
Statements
GEM 231, a second-generation antisense agent complementary to protein kinase A RIalpha subunit, potentiates antitumor activity of irinotecan in human colon, pancreas, prostate and lung cancer xenografts (English)
Sudhir Agrawal
Ekambar R Kandimalla
Dong Yu
Robin Ball
Gina Lombardi
Terri Lucas
Daniel L Dexter
Beth A Hollister